Twitxy Saved

Maureen Hillenmeyer

@MHillenmeyer

Joined May 2013
728 Following 164 Followers 266 Posts

Latest posts 5

Maureen Hillenmeyer @MHillenmeyer
Powered by genetics: speedy development of a targeted therapy.
IDH2 inhibitor + companion diagnostic to identify IDH2 mutation in patients. x.com/rtnarch/status…
Robert Nelsen Verified account @rtnarch Aug 1, 2017
Agios gets fastest approval in history for de-novo target discovery to drug. And a high-impact drug in nasty cancer. endpts.com/celgene-agios-…
View quoted post on X